Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000034396 | SCV000149024 | likely benign | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22703879, 21859464, 25203624, 27600092, 28202063, 28125075, 18199528, 25637381, 26332594, 27060149, 28283864, 27621404, 25637981) |
Labcorp Genetics |
RCV000119123 | SCV000153837 | benign | Familial adenomatous polyposis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000115115 | SCV000172878 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CSER _CC_NCGL, |
RCV000590867 | SCV000190053 | likely benign | Familial multiple polyposis syndrome | 2016-10-01 | criteria provided, single submitter | research | Found in patient having exome sequencing due to suspicion for hereditary colon cancer and/or polyps. Patient is a 53 year old male with a history of ~10 colon polyps and colon cancer diagnosed at age 53. Family history of colon polyps. This interpretation considers GERP score and allele frequency data, in addition to published reports of the variant in the literature, available at the time of review. |
Prevention |
RCV000247116 | SCV000301604 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000343531 | SCV000452041 | likely benign | APC-Associated Polyposis Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000034396 | SCV000602526 | likely benign | not provided | 2018-06-04 | criteria provided, single submitter | clinical testing | The APC c.6821C>T; p.Ala2274Val variant (rs34919187), is reported in patients with colorectal carcinomas (Azzopardi 2008), but is also found in the general population at a frequency greater than expected for the disorder (Amendola 2015, Olfson 2015). This variant is reported as benign or likely benign by several laboratories in ClinVar (Variation ID: 41511), and found in the general population with an overall allele frequency of 0.1% (295/276782 alleles) in the Genome Aggregation Database. The alanine at codon 2274 is weakly conserved, and computational analyses (SIFT, MutationTaster, Align GVGD) predict that this variant is tolerated. Furthermore, this is a missense variant and the vast majority of pathogenic APC variants are truncating nonsense or frameshift variants (see InSiGHt, Kerr 2013). Based on available information, this variant is considered to be likely benign. REFERENCES Link to InSiGHt: https://www.insight-group.org/syndromes/adenomatous-polyposis/. Amendola LM et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015 Mar;25(3):305-15. Azzopardi D et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res. 2008 Jan 15;68(2):358-63. Kerr SE et al. APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. J Mol Diagn. 2013 Jan;15(1):31-43. Olfson E et al. Identification of Medically Actionable Secondary Findings in the 1000 Genomes. PLoS One. 2015 Sep 2;10(9):e0135193. |
Counsyl | RCV000119123 | SCV000786193 | likely benign | Familial adenomatous polyposis 1 | 2018-03-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000119123 | SCV000838143 | likely benign | Familial adenomatous polyposis 1 | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000034396 | SCV000887545 | benign | not provided | 2022-10-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000115115 | SCV000902580 | benign | Hereditary cancer-predisposing syndrome | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034396 | SCV001154477 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | APC: BP4, BS1 |
Institute for Clinical Genetics, |
RCV000034396 | SCV002010864 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000247116 | SCV002069710 | likely benign | not specified | 2020-02-05 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000115115 | SCV002534529 | likely benign | Hereditary cancer-predisposing syndrome | 2021-02-24 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000247116 | SCV002550648 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504864 | SCV002807744 | likely benign | Desmoid disease, hereditary; Familial adenomatous polyposis 1; Hepatocellular carcinoma; Gastric cancer; Colorectal cancer; Gastric adenocarcinoma and proximal polyposis of the stomach | 2021-12-14 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000119123 | SCV004018829 | benign | Familial adenomatous polyposis 1 | 2023-02-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant has been observed in conjunction with multiple pathogenic variants, reducing the likelihood this variant itself is pathogenic. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
Institute for Biomarker Research, |
RCV000115115 | SCV004227997 | benign | Hereditary cancer-predisposing syndrome | 2023-10-31 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034396 | SCV000043135 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
Department of Pathology and Laboratory Medicine, |
RCV001354019 | SCV000591201 | likely benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The APC p.Ala2274Val variant was identified in 3 of 2526 proband chromosomes (frequency: 0.001) from individuals or families with FAP and was not identified in 1938 control chromosomes from healthy individuals (Azzopardi 2008, Johnston 2012). The variant was also identified in dbSNP (ID: rs34919187) as "With Uncertain significance allele", ClinVar (classified as benign by Invitae; as likely benign by nine submitters), COGR, MutDB, LOVD 3.0 (3x), UMD-LSDB (4x as unclassified variant), and in Zhejiang University (1x) database. In UMD the variant was identified with a co-occurring pathogenic APC variant (c.3799dup, p.Thr1267AsnfsX9), increasing the likelihood that the p.Ala2274Val variant does not have clinical significance. The variant was not identified in Cosmic database. The variant was identified in control databases in 295 of 276782 chromosomes at a frequency of 0.001 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 2 of 24012 chromosomes (freq: 0.00008), Other in 14 of 6458 chromosomes (freq: 0.002), Latino in 56 of 34384 chromosomes (freq: 0.002), European in 152 of 126370 chromosomes (freq: 0.001), Ashkenazi Jewish in 66 of 10134 chromosomes (freq: 0.007), and South Asian in 5 of 30780 chromosomes (freq: 0.0002), while the variant was not observed in the East Asian, or Finnish populations. The p.Ala2274 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Clinical Genetics, |
RCV000034396 | SCV001925922 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000034396 | SCV001953850 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000034396 | SCV001968987 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000034396 | SCV001977642 | likely benign | not provided | no assertion criteria provided | clinical testing |